FDA Alerts

Lymphoma
Lymphoma
FDA Roundup: New Options for Rare Conditions
07/08/2014
The FDA has approved two new drugs for the treatment of two rare conditions: peripheral T-cell lymphoma and Glanzmann's thrombasthenia.
07/08/2014
Lymphoma
Lymphoma
FDA approves drug for peripheral T-cell lymphoma
07/07/2014
By Reuters Staff ...
07/07/2014
Blood disorders
Blood disorders
FDA Requires Blood Clot Warning for Testosterone Products
07/03/2014
The FDA is mandating that manufacturers include a general warning on the drug labeling of all approved testosterone products to advise of the risk of blood clots.
07/03/2014
Diabetes Q&A
Diabetes Q&A
FDA Approves Implant to Treat Diabetic Macular Edema
07/01/2014
An implant originally approved to treat certain patients with macular edema is now also approved for patients with diabetes.
07/01/2014
Diabetes Q&A
Diabetes Q&A
FDA Approves Rapid-Acting Inhaled Insulin Powder
06/30/2014
The FDA has approved Afrezza, an inhaled insulin device for use in patients with type 1 and type 2 diabetes.
06/30/2014
Allergy
Allergy
FDA Warns of Life-Threatening Allergic Reactions to OTC Acne Products
06/26/2014
Rare, but serious allergic reactions, including swelling of the face, lips, tongue, eyes, and dyspnea, have been reported.
06/26/2014
all
all
FDA warns of serious allergic reactions with acne products
06/26/2014
...
06/26/2014
skin infection
skin infection
FDA Approves Sivextro To Treat Skin Infections
06/23/2014
The FDA has approved a second antibacterial drug to treat acute bacterial skin and skin structure infections.
06/23/2014
FDA Alerts
FDA Alerts
Genetics startup 23andMe takes step on path to FDA approval
06/23/2014
By...
06/23/2014
Endocrine system
Endocrine system
FDA Requires New Warning on Testosterone Products
06/21/2014
The FDA has called for a new warning label for venous blood clots to be included on all testosterone products.
06/21/2014